MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 105 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2014. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $5,836,000 | +6.3% | 472,000 | +2.1% | 0.16% | -5.7% |
| Q1 2015 | $5,490,000 | +4.8% | 462,100 | -0.3% | 0.18% | -7.4% |
| Q4 2014 | $5,239,000 | +30.6% | 463,600 | +1.5% | 0.19% | +9.9% |
| Q3 2014 | $4,010,000 | +20.5% | 456,700 | 0.0% | 0.17% | +22.0% |
| Q2 2014 | $3,329,000 | +25.9% | 456,700 | -13.0% | 0.14% | +11.0% |
| Q1 2014 | $2,645,000 | -15.3% | 524,800 | -10.4% | 0.13% | -26.2% |
| Q4 2013 | $3,123,000 | – | 585,800 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 514,853 | $2,595,000 | 2.23% |
| GARRISON BRADFORD & ASSOCIATES INC | 98,001 | $494,000 | 0.48% |
| Catalyst Capital Advisors LLC | 380,896 | $1,920,000 | 0.44% |
| Knoll Capital Management, LLC | 160,585 | $809,000 | 0.42% |
| Tekla Capital Management LLC | 757,050 | $3,816,000 | 0.38% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 524,800 | $2,645,000 | 0.13% |
| Integre Asset Management, LLC | 103,493 | $522,000 | 0.12% |
| CAMBRIDGE TRUST CO | 220,003 | $1,109,000 | 0.10% |
| JAMISON EATON & WOOD INC /NJ | 62,782 | $316,000 | 0.09% |
| STONERIDGE INVESTMENT PARTNERS LLC | 88,304 | $445,000 | 0.09% |